The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease
As the period of use of genetically engineered biologic drugs (GEBD) in clinical practice is growing, clinicians are faced with new questions: how to switch from one GEBD to another in case of primary or secondary inefficacy, intolerance to previous GEBD therapy; what should be done after low diseas...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2015-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/180 |
| _version_ | 1797841557801402368 |
|---|---|
| author | N. V. Chichasova |
| author_facet | N. V. Chichasova |
| author_sort | N. V. Chichasova |
| collection | DOAJ |
| description | As the period of use of genetically engineered biologic drugs (GEBD) in clinical practice is growing, clinicians are faced with new questions: how to switch from one GEBD to another in case of primary or secondary inefficacy, intolerance to previous GEBD therapy; what should be done after low disease activity or remission is achieved. The article highlights the recent findings that are relevant for healthcare practitioners. |
| first_indexed | 2024-04-09T16:33:00Z |
| format | Article |
| id | doaj.art-6566554fb5d94818b4ffb673bb6a17cc |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:33:00Z |
| publishDate | 2015-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-6566554fb5d94818b4ffb673bb6a17cc2023-04-23T06:57:00ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-010510611110.21518/2079-701X-2015-5-106-111180The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the diseaseN. V. Chichasova0the First Moscow State Medical University named after I.M. SechenovAs the period of use of genetically engineered biologic drugs (GEBD) in clinical practice is growing, clinicians are faced with new questions: how to switch from one GEBD to another in case of primary or secondary inefficacy, intolerance to previous GEBD therapy; what should be done after low disease activity or remission is achieved. The article highlights the recent findings that are relevant for healthcare practitioners.https://www.med-sovet.pro/jour/article/view/180ревматоидный артритгенно-инженерные биологические препаратыингибиторы фно-arheumatoid arthritisgenetically engineered biologic drugstnf-inhibitors |
| spellingShingle | N. V. Chichasova The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease Медицинский совет ревматоидный артрит генно-инженерные биологические препараты ингибиторы фно-a rheumatoid arthritis genetically engineered biologic drugs tnf-inhibitors |
| title | The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease |
| title_full | The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease |
| title_fullStr | The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease |
| title_full_unstemmed | The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease |
| title_short | The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease |
| title_sort | place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients tactics in different variants of the disease |
| topic | ревматоидный артрит генно-инженерные биологические препараты ингибиторы фно-a rheumatoid arthritis genetically engineered biologic drugs tnf-inhibitors |
| url | https://www.med-sovet.pro/jour/article/view/180 |
| work_keys_str_mv | AT nvchichasova theplaceoftumornecrosisfactoralphainhibitorsinthetreatmentofrheumatoidarthritispatientstacticsindifferentvariantsofthedisease AT nvchichasova placeoftumornecrosisfactoralphainhibitorsinthetreatmentofrheumatoidarthritispatientstacticsindifferentvariantsofthedisease |